News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Present at the Fourth Annual Needham Biotechnology Conference

BOULDER, Colo., May 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Needham Biotechnology Conference on May 25 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event: Needham Biotechnology Conference
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Wednesday, May 25, 2005
Time: 10:30 am Eastern Time
Location: The New York Palace Hotel, New York City
Audio Webcast: www.arraybiopharma.com

About Array BioPharma:

Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Our proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access our drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

SOURCE Array BioPharma Inc.

Tricia Haugeto of Array BioPharma Inc.,
+1-303-386-1193,
thaugeto@arraybiopharma.com